Footage of Myanmar earthquake phenomenon misrepresented as petroleum leak
Text over the clip reads: "Myanmar quake 'rips up the earth' with black oil bubbling up from the ground, fearing explosions or fires".
The video, which includes other footage filmed during the earthquake and visuals created using artificial intelligence, is a clip aired by Formosa Television. The Taiwanese broadcaster later retracted the report and apologised for "misusing AI-generated images circulated online" (archived link).
Still, similar videos and claims have accumulated hundreds of shares on Chinese video-sharing platforms Douyin and Kuaishou.
A massive 7.7-magnitude tremor struck Myanmar's second-largest city of Mandalay on March 28. More than 60,000 people have crowded into temporary displacement sites as major cities lie devastated three weeks after the quake, according to the UN Development Programme (archived link).
Scientists told AFP the viral footage actually shows a phenomenon associated with seismic activity -- not a petroleum leak.
"This is a phenomenon known as liquefaction, which occurs when an earthquake rapidly increases the water pressure in the soil," said Jessada Denduangboripant, a professor in Chulalongkorn University's Department of Biology, on April 16 (archived link).
"It's soil pushed up to the surface, and I don't think it's petroleum as claimed."
A reverse image search found a longer version of the TikTok video published March 28 (archived link).
A broken bridge appears around nine seconds into the video. A speaker says the bridge connects two villages over the Sittang River near the capital Naypyidaw (archived link).
Subsequent reverse image and keyword searches found some of the footage was also published on the YouTube channel Myo Taw, which described it as "groundwater overflowing from the earthquake" (archived link).
Shahar Ben-Zeev, a researcher specialising in earthquakes at the Hebrew University of Jerusalem, told AFP: "I can assure that the photos are of soil liquefaction" (archived link).
The phenomenon, often observed by seismologists, occurs when the earth itself liquefies under the power of a jolt (archived link).
Quakes sometimes hit the soil with such force that its particles come loose, according to the United States Geological Survey (USGS). Ground saturated with water starts behaving like a liquid.
"Many times the fluid flow is concentrated into preferred channels and appears at the surface as 'soil boils' where the water-grain slurry erupts," Ben-Zeev said in an April 16 email.
He said petroleum leaking "is impossible to occur without (the) pre-existence of a very shallow oil reservoir."
USGS geophysicist Susan Hough noticed the same incident during the Myanmar quake, telling American outlet Science News that it could pose a potential danger for cities in river deltas with seismic activity (archived link).
AFP has fact-checked other misinformation about the Myanmar earthquake here.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
29 minutes ago
- Newsweek
Mom Takes Sons on First Roller Coaster, Camera Captures Carnage That Follows
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. A mom has shared pictures of the moment her twin sons' first trip on a roller coaster took an unexpected turn. When Brittany Joy, along with her husband and kids, headed to Orlando, Florida, for a weeklong staycation to mark multiple family birthdays, there was only one thing on the minds of her two youngest sons, twins Bryson and Coleson: Jurassic World VelociCoaster. One of the many attractions at Universal Islands of Adventure, the pair had picked the ride to be their very first experience of a roller coaster. "They were extremely excited," Joy told Newsweek. "Talked about it for months leading up to the trip, kept talking about how they're not scared, and nothing would be too crazy for them and that they could handle it. They were extremely confident." That confidence, unfortunately, would prove misplaced. Bryson and Coleson are excited as they wait to go on their first roller coaster. Bryson and Coleson are excited as they wait to go on their first roller coaster. TikTok/@ Professor Brendan Walker is an aeronautical engineer who has helped develop some of the most-famous roller coasters in the world. In an interview with BBC Science Focus, Walker explained the "psychological levers" he is trying to pull when designing rides of this kind. "If I put you on a roller coaster and blindfolded you, your body's levels of arousal would pretty precisely track the changes in acceleration forces felt around the ride," Walker said. "Roller coasters are successful because they really grab hold of that element of arousal and, because it's so tightly interlinked with physical sensations that we get from the world, we can almost force an emotional experience by the very shape of the roller coaster." Bryson and Coleson certainly had an "experience" on the VelociCoaster, but it wasn't necessarily an emotional one. In truth, the warning signs were there. "The twins have an older brother who didn't want to ride the roller coaster," Joy said. The mom rode alongside one of the twins, with her husband seated alongside the other. It would prove to be a memorable ride—for the parents at least. In a series of slides posted to TikTok under the handle @ Joy shared a picture of the boys looking excited as they queued for the ride. The video then cuts to the four of them mid-ride. By that point, both twins had passed out, though Joy is oblivious to any issue at this stage. "My husband said the twin who was with him passed out before the ride even started. That's why he was fully turned to look at him," Joy said. "Then the twin who was with me passed out after it started, and that's why I didn't realize yet." Joy soon cottoned on that there was an issue, though, with both parents springing into action. "Shortly after that picture was taken, we spent the duration of the ride trying to hold their heads back the best we could so we barely got to enjoy the ride," Joy said. She added that, once the ride was over, the boys woke up with "zero memory" of what had happened. Some might have been disappointed to have missed out after hyping up the experience for so long. The boys had a different take. "We told them they passed out, and they instantly started laughing about it, talked about it for days, telling everyone the story," Joy said. The twins are seen passed out on the roller coaster with their parents. The twins are seen passed out on the roller coaster with their parents. TikTok/@ The fainting incident proved to be the making of them on the trip, too. "It worked out in our favor because the rest of the trip they continued to go on every single ride with no fear and no more fainting," Joy said. The mom's video, meanwhile, went viral, with several viewers flocking to reveal similar experiences. "I honestly never expected it to go viral the way it did, so I'm still shocked by that," Joy said. "It seems as if a lot of people have fallen victim to the same roller coaster."


San Francisco Chronicle
2 hours ago
- San Francisco Chronicle
The U.S. is losing its biotech edge over China — and that's bad news for the Bay Area
From gene therapies to cancer breakthroughs, California has been the driving force behind America's biotechnology industry. But today, that edge is slipping. A National Security Commission on Emerging Biotechnology report to Congress in April stated that the U.S. is dangerously close to falling behind China in biotechnology innovation, and called for urgent investment and strategic coordination to maintain global leadership. Genentech's founding in 1976 in South San Francisco marked the start of the modern biotech era, and, ever since, California has been at the forefront of countless scientific discoveries and medical innovations. However, recent funding cuts and an overreliance on China for manufacturing pipelines leave our nation vulnerable. As the report urges, the U.S. must prioritize biotechnology at the national level or risk relying on China to use this strategic power for good. In 2011, the Chinese government declared biotechnology a ' strategic emerging industry ' and has since committed billions to secure dominance in areas like synthetic biology, gene editing and biomanufacturing. In 2024 alone, China conducted over 7,100 clinical drug trials, surpassing the United States and accounting for nearly 40% of global trial activity. Despite U.S. tariffs under the Trump administration designed to counter China's economic influence, China's gross domestic product has remained strong, fueling even greater investment in strategic sectors like biotechnology. By contrast, the U.S. continues to lose ground, constrained by outdated regulatory frameworks and a lack of coordinated federal strategy. While China is building a biotech empire with deliberate, state-backed coordination, the U.S. is stuck playing defense with shrinking budgets. U.S. federal support for biomedical research is slipping, with the budget for the National Institutes of Health facing a 40% cut in the coming year. For a region like the Bay Area, home to some of the world's most promising biotech startups and research institutions, these cuts have a direct toll, including the termination of $314 million in funding that was to be used to train the next generation of biomedical and health researchers. Major institutions like UCSF, Stanford and UC Berkeley are now bracing for delayed projects, staffing freezes and reductions in early-career fellowships that are vital to sustaining long-term innovation. On a national level, promising studies have been halted midstream, leaving research gaps in breakthrough treatments for cancer, Alzheimer's disease and other major infectious diseases that impact millions of Americans. When U.S. investment in domestic biotech falters, it slows innovation at home and creates an opening for global competitors to step in. China's government is strategically positioning its biotech sector to fill the gap left by stalled American research. Just last month, U.S. pharmaceutical firms signed 14 licensing deals with Chinese biotech companies worth up to $18.3 billion, underscoring our growing dependence on China's rapidly maturing R&D capabilities. This shift carries significant implications for California. It is home to over 16,500 life sciences companies and establishments, more than any other state, according to the California Biotechnology Foundation. The state directly employs more than 466,000 workers and generates more than $414 billion in annual economic output. In 2023, California led the nation in venture capital investment, raising over $34 billion for life science companies. Further, California accounted for 40% of all U.S. life sciences patents filed in 2023, and more bioscience patents are issued to California researchers than to those in any other state. Losing ground to China isn't just an economic risk; it's also a national security threat that could reshape who controls the future of health care. While the U.S. system is built on competition and patient outcomes, China's state-controlled model prioritizes strategic control and global influence. In America, ethical safeguards, transparency and regulatory review shape medical progress. In China, the government's control allows for faster approvals but also looser oversight, creating the risk of untested or misused science. The National Security Commission on Emerging Biotechnology warned that China's biotech advances could be weaponized — from battlefield-ready biologics to more nefarious applications. As a scientist working in biotechnology in the Bay Area, I understand that California plays a central role in this global race. From early-stage research in university labs to large-scale manufacturing by leading biotech firms, the state's infrastructure, talent and capital drive America's competitiveness. The Bay Area remains one of the most dense and productive biotech ecosystems in the world, thanks to its concentration of top-tier research institutions, world-class hospitals, a culture of entrepreneurship and the ability to attract the world's best and brightest to its academic and industrial ecosystem. But even here, the warning signs are hard to ignore. Federal NIH cuts have already disrupted major research projects at UC campuses, impacting our ability to attract talented students to our graduate and postdoctoral research programs, while venture capital is increasingly eyeing faster-moving regulatory environments abroad, preferring to license in late-stage assets from China instead of funding early-stage research at home. If Washington fails to prioritize a national biotech strategy, California's innovation engine could slow just as competitors abroad gain momentum. The state's economic future, public health leadership and ability to attract global talent are all at stake. China is no longer a distant biotech challenger and is actively reshaping the industry with its speed, regulatory agility and cost-efficiency, shifting the innovation center of gravity away from the U.S. The National Security Commission on Emerging Biotechnology has made clear that this is not just a matter of competition, but a strategic threat with long-term consequences for public health and national security. If America is to remain a global leader in biotechnology, we must urgently invest in our domestic research ecosystem and rebuild the infrastructure that has powered decades of discovery or be forced to surrender it to a rival that plays by different rules. Ash Jogalekar is a scientist and science writer based in the Bay Area. He is a scientist in residence at the Oppenheimer Project and works on emerging threats and technology risks in areas like biotechnology and AI.
Yahoo
6 hours ago
- Yahoo
Life on the Moon? Lunar soil could help humans live on the Moon, study finds
The soil on the Moon might be able to sustain life, according to a new study. Researchers from the Chinese University of Hong Kong developed a technology to extract water from lunar soil and used it to convert carbon dioxide into oxygen and chemical fuel. The technology does this by converting light from the Sun into heat. According to the study, published in the Cell Press journal Joule, the research could 'potentially open new doors for future deep space exploration' because it could mitigate the expensive costs needed to bring essential resources such as water to the Moon. A single gallon (3.78 litres) of water costs $83,000 (€71,230) to ship up by rocket, the study continued, with one astronaut drinking roughly four gallons (15.14 litres) a day. 'We never fully imagined the 'magic' that the lunar soil possessed,' said lead researcher Lu Wang. Related US Senate greenlights billions for Moon missions despite Elon Musk's opposition However, the study notes that any strategies that are already in place to extract water from the surface of the Moon involve multiple 'energy-intensive' steps and do not break down how much CO2 is used by fuel. The Moon's extreme lunar environment will still make it challenging to harvest more oxygen and water from the land, the study continued, because there are 'drastic temperature fluctuations,' radiation and low gravity to deal with. The CO2 emitted from the breaths of the astronauts won't be enough to supply all the water, fuel and oxygen that the team of astronauts might need.